Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2019Clinical Epidemiology and Global HealthOpen Access

Economic evaluation of End Stage Renal Disease treatments in Iran

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAmirali MoradpourMTMahmoud TavakkoliMashhad University of Medical Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moradpour et al. (2019) studied this question.

synapsesocial.com/papers/6aaa61d1f2bb4cdcbefdc48chttps://doi.org/10.1016/j.cegh.2019.07.001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cost of Dialysis Therapy by Modality in Manitoba2018 · 77 citations
  2. 2Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–20142017 · 164 citations
  3. 3Cost-Effectiveness Analysis of the Spanish Renal Replacement Therapy Program2011 · 32 citations
  4. 4Comparison of Hemodialysis and Peritoneal Dialysis — a Cost–Utility Analysis2002 · 151 citations
  5. 5A time preference measure of the social discount rate for Iran2018 · 39 citations